在美国，每年都有将近5万名新增确诊的癌症患者，而这些患者大部分年龄在35岁以下，尽管这个数据如此惊人，但是以现在如此先进的医疗技术手段，癌症患者的生存率已有大幅提高。因此，对于男性和女性的癌症患者来说，诸如生儿育女的生活质量问题，称为了癌症治疗所需考虑的重要组成部分。

    不幸的是，众多的治疗手段往往把消除肿瘤的恶性程度放在首位，而将患者的生育要求置于次要地位。在这些案例中，患者的生育要求应当在癌症治疗的早期阶段得到重视和考虑，如果可能的话，应当满足他们生儿育女的要求。这其中包括肿瘤治疗和肿瘤本身对生儿育女的影响，如对患者及其后代健康风险的评估等。

    本文译自Lancet，如转载请注明出处。

    Annually, more than 50 000 cancer diagnoses are made in the USA in patients under the age of 35 years. Despite this staggering statistic, medical advancements have substantially improved survival rates. Thus, for both male and female patients with cancer, quality-of-life issues, such as fertility preservation and parenthood, have become an essential component of treatment. Unfortunately, many of the treatments to eradicate malignant processes can also compromise reproductive function. In these cases, fertility preservation should be discussed and initiated with early treatment planning, to allow the best chance for future parenthood, when appropriate. The effects of cancer and cancer treatments on fertility and future parenthood, including health risks for patients, their gametes, and offspring are discussed.